At LogiPharma USA 2026, leaders from J&J, Sun Pharma, Accord Healthcare, and Freehand discussed visibility, redundancy tradeoffs, and AI's role in resilient pharma supply chains. Supply chain ...

AI should not be framed as influencing prescribing; it can close the information-access gap by delivering brand-approved, ...

Cardinal Health extended its CVS distribution arrangement through June 30, 2032, maintained current service scope, and reaffirmed fiscal 2027 non-GAAP EPS guidance of $12.40–$12.60. McKesson’s ...

Resilience is positioned as an anticipatory capability enabled by visibility, planning maturity, and partnerships, not merely reactive contingency management amid disruption and cost pressure. AI ...

GLP-1 demand is straining pharma cold chain capacity, from tighter temperature thresholds and rising load rejections to fuel costs and trailer backlogs. Shipping pharmaceuticals has always been one of ...

Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke. There are nine pieces in this issue. Three left me with ...

In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity. Welcome to Pharma Pulse, a ...

Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke.

Most favored nation agreements now encompass 26 manufacturers, signaling rapid normalization of pricing constraints across portfolios and compressing traditional strategic levers. List-price/rebate ...